TFEB and cardiovascular disorder: Natural activators of autophagy were observed to exert beneficial effects in pre-clinical models of cardiovascular diseases, acting on specific molecular targets, such as the mechanistic target of rapamycin complex I (mTORC1), transcription factor EB (TFEB), and 5′ adenosine monophosphate-activated protein kinase [8,9].